YLR154W-F Antibody

Shipped with Ice Packs
In Stock

Description

Definition of YLR154W-F Antibody

YLR154W-F is a dubious open reading frame (ORF) in the Saccharomyces cerevisiae genome (Baker’s yeast strain ATCC 204508 / S288c). It is annotated as "unlikely to encode a functional protein" due to a lack of experimental or comparative sequence evidence supporting its expression or role in cellular processes . Antibodies targeting YLR154W-F, such as CSB-PA313637XA01SVG (Cusabio), are commercially produced for research purposes, though their utility is limited by the questionable biological relevance of the target .

Genomic and Protein Characteristics

Key features of the YLR154W-F locus and hypothetical protein include:

AttributeDetail
Gene Systematic NameYLR154W-F
UniProt IDP0C5P9
SpeciesSaccharomyces cerevisiae (strain ATCC 204508 / S288c)
Protein StatusNon-translated ("This locus is not translated into a protein")
Sequence ValidationClassified as "dubious" due to lack of transcriptional/translational evidence

The absence of detectable protein expression is further supported by:

  • No protein half-life or abundance data in SILAC or mass spectrometry studies .

  • No conserved domains or motifs identified via InterProScan analysis .

4.1. Yeast Genome Annotation Challenges

Approximately 5% of S. cerevisiae ORFs are labeled "dubious" due to gaps between computational predictions and empirical validation . YLR154W-F falls into this category, with no evidence of:

  • Transcriptional activity under standard conditions.

  • Evolutionary conservation across yeast species.

4.2. Implications for Antibody Development

Antibodies targeting non-functional ORFs like YLR154W-F highlight broader issues in reagent validation. For instance:

  • False positives: Antibodies may bind nonspecifically to unrelated epitopes.

  • Resource misallocation: Commercial production without biological relevance risks wasted research effort .

Comparative Analysis of Antibody Reagents

The table below contrasts YLR154W-F antibodies with validated yeast protein antibodies:

ParameterYLR154W-F AntibodyValidated Antibody (e.g., YLR402W)
Target ExistenceDubious ORFConfirmed protein (e.g., Q06057)
Experimental SupportNoneAbundance data, PTMs, domains
ApplicationsHypothetical studiesFunctional assays (e.g., enzyme activity)

Future Directions

  • Reannotation efforts: Improved genomic sequencing and proteomic tools may resolve YLR154W-F’s status.

  • Antibody validation standards: Require orthogonal evidence (e.g., CRISPR knockout models) for commercial antibodies .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLR154W-F antibody; Putative uncharacterized protein YLR154W-F antibody
Target Names
YLR154W-F
Uniprot No.

Q&A

What is YLR154W-F and why is it classified as a dubious ORF?

YLR154W-F is a genomic sequence in Saccharomyces cerevisiae (baker's yeast strain ATCC 204508/S288c) that has been computationally identified as a potential open reading frame. It is classified as "dubious" because there is insufficient experimental or comparative sequence evidence supporting its expression or biological role. The sequence is annotated in protein databases (UniProt ID: P0C5P9) but is flagged as "non-translated" with the specific note that "this locus is not translated into a protein".

The dubious classification stems from several factors:

  • Absence of detectable transcription under standard laboratory conditions

  • Lack of evolutionary conservation across related yeast species

  • No protein detection in comprehensive proteomic studies

  • Absence of functional domains or recognizable protein motifs

Approximately 5% of S. cerevisiae ORFs fall into this "dubious" category, highlighting the gap between computational gene prediction and empirical validation.

What experimental approaches have been used to investigate YLR154W-F expression?

Researchers have employed multiple methodologies to investigate potential YLR154W-F expression, all yielding negative results:

  • Mass spectrometry-based proteomics: High-throughput proteome studies have failed to detect peptides corresponding to YLR154W-F in various growth conditions.

  • SILAC (Stable Isotope Labeling with Amino acids in Cell culture): This quantitative proteomics approach has not identified YLR154W-F in protein abundance datasets.

  • Transcriptional profiling: RNA-seq and microarray analyses have not detected significant transcription from this locus under standard laboratory conditions.

  • Protein half-life studies: No measurable half-life data exists for YLR154W-F, consistent with absence of protein expression.

  • Domain analysis: InterProScan analysis has failed to identify conserved domains or motifs that would suggest functionality.

What are the key specifications of commercially available YLR154W-F antibodies?

Commercial YLR154W-F antibodies are available despite the questionable biological relevance of the target. Key specifications include:

AttributeDetails
Catalog InformationCat. No. BT1654057 (Cusabio)
Antibody IDCSB-PA313637XA01SVG (Cusabio)
Shipping ConditionsWith ice packs
Host SpeciesTypically rabbit (for polyclonal)
Antibody TypePolyclonal (most common)
ApplicationsELISA, Western Blot (with identification verification recommended)
Target SpeciesSaccharomyces cerevisiae (strain ATCC 204508/S288c)
Purification MethodUsually antigen-affinity

It's important to note that these antibodies are produced primarily for research purposes, though their utility is inherently limited by the questionable existence of the target protein.

What methodological challenges exist when working with antibodies targeting dubious ORFs?

Working with antibodies targeting dubious ORFs like YLR154W-F presents several significant methodological challenges:

Cross-reactivity and false positives: The primary concern is antibody binding to unrelated epitopes, producing misleading results. This is particularly problematic with dubious ORFs since:

  • Without a validated target protein, standard validation procedures are compromised

  • Specificity controls (knockouts, competing peptides) may be difficult to interpret

  • Bands detected in immunoblotting may represent entirely different proteins

Signal interpretation challenges: Any signal detected must be interpreted with exceptional caution:

  • Is the signal due to low-level expression of the dubious ORF?

  • Is it cross-reactivity with a related protein?

  • Could experimental conditions induce expression of normally silent ORFs?

Validation complexity: Standard validation approaches must be adapted:

  • Negative controls must be especially rigorous

  • Mass spectrometry verification of immunoprecipitated proteins becomes essential

  • Sequential epitope mapping may be necessary to confirm specificity

Resource allocation concerns: Using antibodies against dubious ORFs risks misallocation of research resources in terms of time, materials, and effort.

How can researchers distinguish between true YLR154W-F signals and experimental artifacts?

For researchers determined to investigate YLR154W-F despite its dubious status, several stringent approaches can help distinguish true signals from artifacts:

Comprehensive negative controls:

  • Include wildtype and gene deletion strains (if available)

  • Use pre-immune serum controls

  • Perform peptide competition assays with the immunizing peptide

  • Include heterologous expression systems without the target

Multi-method verification:

  • Combine antibody-based detection with orthogonal methods

  • Employ tagged versions of the putative protein under native promoter control

  • Use RNA-seq or qRT-PCR to confirm transcription before investigating protein expression

  • Apply ribosome profiling to detect any translation events

Mass spectrometry validation:

  • Immunoprecipitate with the YLR154W-F antibody

  • Analyze precipitated material by LC-MS/MS

  • Compare detected peptides against the full proteome database

  • Determine whether any detected peptides uniquely match YLR154W-F

Signal quantification:

  • Compare signal intensities across multiple experimental conditions

  • Assess signal-to-noise ratios against established thresholds

  • Apply statistical analyses to distinguish weak true signals from background

How does YLR154W-F compare to other dubious ORFs and experimentally validated yeast proteins?

Understanding YLR154W-F in context requires comparative analysis with both other dubious ORFs and validated proteins:

ParameterYLR154W-F (Dubious ORF)Validated Protein (e.g., YLR402W)Related Dubious ORF (e.g., YLR154W-A/TAR1)
Protein StatusNon-translated/DubiousConfirmed expressionAntisense RNA transcript with potential coding function
UniProt IDP0C5P9Q06057YLR154W-A is also known as TAR1
Experimental SupportNoneAbundance data, PTMs, functional domainsLimited evidence for expression
Evolutionary ConservationNot conservedTypically conserved across speciesVariable conservation
Antibody UtilityQuestionableValidated for multiple applicationsLimited validation
Associated PhenotypesNone reportedGrowth defects in knockout strainsPotential role in ribosomal RNA expression

This comparison highlights the fundamental differences between dubious ORFs like YLR154W-F and experimentally validated proteins. The related locus YLR154W-A (TAR1) represents an interesting middle ground, as it appears to be transcribed antisense to ribosomal RNA and may have some coding potential .

What alternative experimental strategies exist for studying potential functions of dubious ORFs?

When traditional antibody-based approaches prove limiting, researchers can employ alternative strategies to investigate potential functions of dubious ORFs like YLR154W-F:

Genome-wide functional screens:

  • CRISPR-Cas9 screens targeting the locus under various stress conditions

  • Transposon-based mutagenesis libraries to identify potential phenotypes

  • Synthetic genetic array (SGA) analysis to detect genetic interactions

Directed evolution approaches:

  • Overexpression of the dubious ORF to force potential expression

  • Codon optimization to enhance translation efficiency

  • Fusion to reporter tags with detection thresholds below standard proteomics

Computational re-annotation:

  • Apply newer gene prediction algorithms with improved accuracy

  • Perform comparative genomics across multiple yeast strains and species

  • Analyze ribosome profiling data for translation events in the region

Transcriptomics under extreme conditions:

  • Subject cells to diverse stress conditions that might induce expression

  • Analyze strain-specific transcription patterns across different genetic backgrounds

  • Examine transcription in industrial yeast strains versus laboratory strains

What controls should be included when validating YLR154W-F antibodies?

Proper validation of YLR154W-F antibodies requires a comprehensive set of controls specifically adapted for dubious ORFs:

Essential negative controls:

  • Genetic deletion strains: Create a precise deletion of the YLR154W-F locus to confirm antibody specificity

  • Pre-immune serum comparison: Compare signals from the antibody preparation to pre-immune serum from the same animal

  • Peptide competition: Pre-incubate the antibody with excess immunizing peptide to block specific binding

  • Non-target species: Test the antibody against non-yeast samples to assess cross-reactivity

Positive controls (challenging for dubious ORFs):

  • Epitope-tagged constructs: Create a tagged version of YLR154W-F and express it under a strong promoter

  • Synthetic peptide detection: Demonstrate antibody recognition of the synthetic peptide used for immunization

  • Heterologous expression: Express YLR154W-F in bacterial or mammalian cells as a reference standard

Quantitative validation metrics:

  • Signal-to-noise ratio determination across multiple exposure times

  • Concentration-dependent signal with recombinant or synthetic standards

  • Reproducibility assessment across multiple antibody lots

  • Cross-validation with multiple antibodies raised against different epitopes of YLR154W-F

How might the study of YLR154W-F integrate with broader yeast genomics research?

Despite its dubious status, YLR154W-F research can contribute to broader yeast genomics in several ways:

Genome annotation refinement:

  • Improve computational prediction models for gene identification

  • Develop better criteria for distinguishing between true genes and artifacts

  • Enhance understanding of regulatory elements that might overlap with dubious ORFs

Evolutionary genomics:

  • Examine how dubious ORFs like YLR154W-F emerge and disappear during genome evolution

  • Investigate whether some dubious ORFs represent "proto-genes" in evolutionary transition

  • Study strain-specific differences in ORF composition and arrangement

Functional genomics integration:

  • Include dubious ORFs in genome-wide functional analyses

  • Investigate potential regulatory roles of transcription across dubious ORF regions

  • Examine potential translation under non-standard conditions

Methodological advancement:

  • Develop improved protocols for validating antibodies against low-abundance or questionable targets

  • Create new computational tools for distinguishing between meaningful signals and artifacts

  • Establish guidelines for reporting research on dubious ORFs

What are the implications of YLR154W-F's genomic context for experimental design?

The genomic context of YLR154W-F significantly influences experimental design considerations:

Overlapping genomic features:

  • Determine whether YLR154W-F overlaps with other functional elements (e.g., enhancers, silencers)

  • Assess proximity to known genes that might be affected by manipulations of the YLR154W-F locus

  • Consider potential antisense transcription relationships with neighboring genes

Chromatin structure considerations:

  • Evaluate the chromatin state of the YLR154W-F region (active, repressed, heterochromatic)

  • Analyze histone modifications across the locus under different conditions

  • Consider the impact of nearby nucleosome positioning on potential expression

Strain-specific variations:

  • Compare the YLR154W-F locus across different yeast strains beyond the reference S288c

  • Assess whether industrial or wild yeast strains show conservation or variation at this locus

  • Determine if strain-specific genetic backgrounds influence detection results

Experimental modification implications:

  • Design genetic manipulations to minimize disruption of neighboring genes

  • Consider potential polar effects when inserting tags or markers near the locus

  • Develop strategies for locus-specific manipulation without broader genomic consequences

What value might dubious ORF research bring to broader biological understanding?

Research on dubious ORFs like YLR154W-F, while challenging, offers several potential contributions to broader biological understanding:

Genome annotation improvement:

  • Refinement of gene prediction algorithms through systematic study of false positives

  • Development of improved criteria for distinguishing genuine genes from computational artifacts

  • Better understanding of minimum requirements for functional protein-coding genes

Evolutionary insights:

  • Exploration of the "proto-gene" hypothesis, where new genes emerge from non-coding sequences

  • Understanding of how genome architecture evolves through creation and loss of ORFs

  • Elucidation of mechanisms driving genomic innovation and complexity

Methodological advancement:

  • Development of more rigorous standards for protein existence validation

  • Improvement of antibody validation protocols for difficult or low-abundance targets

  • Creation of new analytical approaches for distinguishing true signals from artifacts

Biological discovery potential:

  • Occasional reclassification of dubious ORFs as functional under specific conditions

  • Identification of novel regulatory mechanisms involving apparently non-coding regions

  • Discovery of condition-specific expression patterns that conventional approaches might miss

What future technologies might better resolve the status of dubious ORFs like YLR154W-F?

Emerging technologies promise to address current limitations in studying dubious ORFs:

Advanced proteomics approaches:

  • Single-cell proteomics for detection of cell-specific or transient expression

  • Enhanced mass spectrometry sensitivity for extremely low-abundance proteins

  • Targeted proteomics methods with improved detection limits

  • De novo peptide sequencing to identify unexpected translation products

Improved genomic technologies:

  • Long-read sequencing for better structural variant detection and genome assembly

  • CRISPR-based screening at unprecedented scale and precision

  • Nanopore direct RNA sequencing for comprehensive transcriptome analysis

  • Spatial transcriptomics to capture location-specific expression

Computational advances:

  • Machine learning approaches for improved gene prediction

  • Integrative analysis pipelines combining multiple data types

  • Better algorithms for distinguishing between coding and non-coding sequences

  • Advanced statistical methods for separating signal from noise in high-throughput data

Novel functional approaches:

  • Massively parallel reporter assays for regulatory element identification

  • Synthetic biology approaches to test minimal requirements for gene functionality

  • Systems-level perturbation analysis to detect subtle phenotypic effects

  • Evolutionary reconstruction experiments to test proto-gene hypotheses

By leveraging these emerging technologies, researchers may finally resolve the status of dubious ORFs like YLR154W-F, potentially uncovering new biological principles in the process.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.